Bottom line
Is GDOC a good fund? The bottom line
GDOC is a managed health care sector ETF from Goldman Sachs.
Annual fees run 0.75% — about $75 a year on every $10,000 invested, cheaper than 66% of health care sector funds we track.
It returned −1.6% over one year (as of Dec 31, 2024, per its prospectus).
With $20.1 million in net assets and 42 holdings, its largest position is Eli Lilly & Company (13.3%) and the top 10 make up 57.3% of the portfolio.
The closest lower-cost alternative we found is VGHCX (0.33%, 50% top-holdings overlap).
What to watch
- Concentrated: top 10 holdings are 57.3% of assets
- Small fund ($20.1 million) — small funds are likelier to close
Updated Nov 19, 2026
What GDOC invests in
The Goldman Sachs Future Health Care Equity ETF (the Fund) seeks long-term growth of capital.
The Fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) (Net Assets) in equity investments in U.S. and non-U.S. health care companies. Goldman Sachs Asset Management, L.P. (GSAM or the Investment Adviser) generally defines a health care company as a company in the health care sector. The Investment Adviser may use the classifications assigned by third parties but is not required to do so. The Fund seeks to achieve its investment objective by investing in health care companies that the Investment Adviser believes are driving innovation in health care, by developing either new treatments or new technologies, primarily in the fields of genomics, precision medicine, technology-enabled procedures and digital healthcare. The Investment Adviser seeks to identify companies at various growth…
From the fund's prospectus (filed Dec 29, 2025).
GDOC performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| GDOC | −1.6% | — | — |
| Health Care Sector median | +14.5% | +4.2% | +7.9% |
Source: Fund prospectus, as of Dec 31, 2024
What GDOC costs
On a $10,000 investment, GDOC's 0.75% expense ratio costs about $75 a year. The prospectus estimates $930 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.
GDOC top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Eli Lilly & Company LLY | 13.28% |
| 2 | Johnson & Johnson JNJ | 8.07% |
| 3 | Merck & Company Inc MRK | 5.94% |
| 4 | Guardant Health Inc GH | 5.34% |
| 5 | Astrazeneca Plc AZN | 4.84% |
| 6 | Thermo Fisher Scientific Inc TMO | 4.52% |
| 7 | Argenx Se ARGX | 4.07% |
| 8 | Intuitive Surgical Inc ISRG | 3.90% |
| 9 | Boston Scientific Corp BSX | 3.78% |
| 10 | Hoya Corp 7741 | 3.53% |
Source: SEC Form N-PORT, period ended May 31, 2026
The top 10 make up 57.3% of the fund. See all top 25 holdings and asset mix →